Early buyers will receive 10% customization on this report.
Growth in the vascular patches market is mainly driven by the rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases, the increasing number of vascular surgeries performed, and the increasing adoption of biological patches. The emerging markets are expected to offer a wide range of growth opportunities for players in the market.
On the other hand, product failures and recalls is expected to limit market growth in the coming years. The need for highly skilled professionals may also challenge market growth to a certain extent.
The biologic vascular patch segment accounted for the largest share of the market in 2017
Based on material, the vascular patches market is segmented into biologic vascular patches and synthetic vascular patches. Of all these product segments, biologic vascular patches accounted for the largest share of the market in 2017.
The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of biologic vascular patches such as superior biocompatibility, ease of use, minimal suture line bleeding, and reduced rates of infection in comparison with synthetic patches.
The hospitals & clinics segment is estimated to grow at the highest CAGR during the forecast period.
Based on end user, the vascular patches market has been segmented into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment is estimated to grow at the highest CAGR during the forecast period. The growth of this end-user segment is majorly attributed to factors such as the growth in the number of vascular procedures in hospitals and improving healthcare infrastructure in several developing countries across the globe.
North America commanded the largest share of the market in 2017.
Based on region, the vascular patches market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America accounted for the largest share of the vascular patches market. The growing prevalence of vascular diseases and the rising geriatric population in this region as well as the presence of all the major players in this region are the major factors supporting the growth of the vascular patches market in North America.
The major players in the vascular patches market include Terumo Corporation (Japan), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
